Carmen Volkart Joins Tactile Medical’s Board of Directors

Tactile Systems Technology Inc. has appointed Carmen Volkart to the company’s Board of Directors.
 
“Carmen joins our board with more than 40 years of experience in financial and managerial positions, including extensive experience leading medical device companies,” Tactile Medical Chairman Bill Burke said. “We are glad to welcome Carmen to Tactile Medical and look forward to benefiting from her operating expertise and strategic insight.”
 
Since 2018, Volkart has served as chief financial officer (CFO) NatureWorks LLC, a privately-held advanced materials company and developer of renewably sourced polymers and chemicals. Before joining NatureWorks, she served as CFO of NxThera Inc., a privately-held medical device company focused on benign prostatic hyperplasia treatment, from 2012 until its acquisition by Boston Scientific Corp. in 2018. From 2010 to 2012, Volkart was CFO of Tornier N.V., a medical device company focused on treating musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot. She led Tornier through a successful initial public offering in 2011.
 
Prior to Tornier, Volkart was chief operating and financial officer, corporate secretary, compliance officer, and treasurer of Spine Wave Inc., a privately-held medical device company focused on minimally invasive spine surgery and expandable interbody devices, from 2006 to 2010. From 2004 to 2006, Volkart served as executive vice president and CFO of American Medical Systems Inc., a publicly traded medical device company focused on male and female pelvic health. Her career history also includes significant experience in various financial and managerial positions at both Medtronic Inc., from 1992 to 2004, and Honeywell Inc., from 1982 to 1992.
 
Tactile Medical develops and markets at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease. The company collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs, and improve the quality of life for tens of thousands of patients annually.